Probity Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Probity Advisors, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $21.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$21.0M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 12,288 | $2.7M |
| LLYELI LILLY & Co | 2,675 | $2.5M |
| MRKMerck & Co., Inc. | 20,319 | $2.4M |
| JNJJOHNSON & JOHNSON | 9,437 | $2.3M |
| GILDGILEAD SCIENCES, INC. | 12,021 | $1.7M |
| PFEPFIZER INC | 48,878 | $1.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 24,452 | $1.3M |
| SNYSanofi | 23,679 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 18,539 | $1.1M |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 43,523 | $806K |
| PMPhilip Morris International Inc | 4,213 | $697K |
| ELANElanco Animal Health Inc | 20,750 | $497K |
| MRNAModerna, Inc. | 9,144 | $465K |
| ZTSZoetis Inc. | 2,794 | $330K |
| GEHCGE HealthCare Technologies Inc. | 4,314 | $307K |
| ABTABBOTT LABORATORIES | 2,961 | $304K |
| GMEDGlobus Medical Inc. | 3,513 | $303K |
| BNTXBioNTech SE | 3,231 | $287K |
| ZBHZimmer Biomet Holdings Inc. | 2,713 | $245K |
| BIIBBIOGEN INC. | 1,131 | $207K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.